This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1998 Apr;138(4):374-5.

doi: 10.1530/eje.0.1380374.

The sodium iodide symporter: its emerging relevance to clinical thyroidology

C Spitzweg¹, A E Heufelder

Affiliations

PMID: 9578502
DOI: 10.1530/eje.0.1380374

Review

The sodium iodide symporter: its emerging relevance to clinical thyroidology

C Spitzweg et al. Eur J Endocrinol. 1998 Apr.

. 1998 Apr;138(4):374-5.

doi: 10.1530/eje.0.1380374.

Authors

C Spitzweg¹, A E Heufelder

Affiliation

¹ Division of Endocrinology, Medizinische Klinik, Klinikum Innenstadt, Ludwig-Maximilians-University, Munich, Germany.

PMID: 9578502
DOI: 10.1530/eje.0.1380374

No abstract available

PubMed Disclaimer

Similar articles

Molecular study of the sodium-iodide symporter (NIS): a new field in thyroidology.
Dohan O, De la Vieja A, Carrasco N. Dohan O, et al. Trends Endocrinol Metab. 2000 Apr;11(3):99-105. doi: 10.1016/s1043-2760(00)00237-x. Trends Endocrinol Metab. 2000. PMID: 10707050
The Na+/I- symporter (NIS): recent advances.
Levy O, De la Vieja A, Carrasco N. Levy O, et al. J Bioenerg Biomembr. 1998 Apr;30(2):195-206. doi: 10.1023/a:1020577426732. J Bioenerg Biomembr. 1998. PMID: 9672241 Review.
Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells.
Kogai T, Hershman JM, Motomura K, Endo T, Onaya T, Brent GA. Kogai T, et al. Endocrinology. 2001 Aug;142(8):3369-79. doi: 10.1210/endo.142.8.8344. Endocrinology. 2001. PMID: 11459780
[Sodium-iodine symporter of the thyroid gland. Discovery, characterization, clinical relevance and prospects].
Spitzweg C, Heufelder AE. Spitzweg C, et al. Dtsch Med Wochenschr. 1999 Sep 17;124(37):1077-84. doi: 10.1055/s-2007-1024485. Dtsch Med Wochenschr. 1999. PMID: 10520309 Review. German. No abstract available.
Update on the thyroid sodium iodide symporter: a novel thyroid antigen emerging on the horizon.
Spitzweg C, Heufelder AE. Spitzweg C, et al. Eur J Endocrinol. 1997 Jul;137(1):22-3. doi: 10.1530/eje.0.1370022. Eur J Endocrinol. 1997. PMID: 9242197 Review. No abstract available.

See all similar articles

Cited by

Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines.
Fröhlich E, Brossart P, Wahl R. Fröhlich E, et al. Eur J Nucl Med Mol Imaging. 2009 May;36(5):780-90. doi: 10.1007/s00259-008-1024-6. Epub 2008 Dec 24. Eur J Nucl Med Mol Imaging. 2009. PMID: 19107477
Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer.
Ma C, Xie J, Chen Q, Wang G, Zuo S. Ma C, et al. Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD007956. doi: 10.1002/14651858.CD007956.pub2. Cochrane Database Syst Rev. 2009. PMID: 19821441 Free PMC article.
Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer.
Ma C, Xie J, Jiang Z, Wang G, Zuo S. Ma C, et al. Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1778-85. doi: 10.1007/s00259-009-1368-6. Epub 2010 Feb 4. Eur J Nucl Med Mol Imaging. 2010. PMID: 20130857 Review.
Morphometric and functional changes of salivary gland dysfunction after radioactive iodine ablation in a murine model.
Choi JS, Park IS, Kim SK, Lim JY, Kim YM. Choi JS, et al. Thyroid. 2013 Nov;23(11):1445-51. doi: 10.1089/thy.2012.0243. Epub 2013 Jul 25. Thyroid. 2013. PMID: 23607283 Free PMC article.
Expression of sodium iodide symporter in benign and malignant human thyroid tissues.
Lin JD, Hsueh C, Chao TC, Weng HF. Lin JD, et al. Endocr Pathol. 2001 Spring;12(1):15-21. doi: 10.1385/ep:12:1:15. Endocr Pathol. 2001. PMID: 11478264

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information